Mike Catlin's most recent trade in Kiromic BioPharma Inc was a trade of 18,000 Restricted Stock Award done . Disclosure was reported to the exchange on March 18, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kiromic BioPharma Inc | Mike Catlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 18,000 | 25,500 | - | - | Restricted Stock Award |